2019
Effect of β-blockers on triggering of symptomatic atrial fibrillation by anger or stress
Lampert R, Burg MM, Jamner LD, Dziura J, Brandt C, Li F, Donovan T, Soufer R. Effect of β-blockers on triggering of symptomatic atrial fibrillation by anger or stress. Heart Rhythm 2019, 16: 1167-1173. PMID: 31171436, PMCID: PMC6759206, DOI: 10.1016/j.hrthm.2019.03.004.Peer-Reviewed Original ResearchConceptsAtrial fibrillationΒ-blockersAF episodesHistory of AFControl periodSymptomatic AF episodesSymptomatic atrial fibrillationΒ-blocker useExclusion of patientsPersistent atrial fibrillationHolter monitoringAF symptomsPatientsPatient exposureCase periodFibrillationMood statesEpisodesEvent monitorDeleterious physiological responsesExposurePhysiological responsesDiary dataSotalol
2016
Post-traumatic Stress Disorder and Cardiovascular Disease
Burg MM, Soufer R. Post-traumatic Stress Disorder and Cardiovascular Disease. Current Cardiology Reports 2016, 18: 94. PMID: 27566327, DOI: 10.1007/s11886-016-0770-5.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesHumansHypertensionMyocardial InfarctionPrevalenceProspective StudiesRisk FactorsStress Disorders, Post-TraumaticConceptsPost-traumatic stress disorderCardiovascular diseaseStress disorderIncident hypertension riskIncident cardiovascular diseaseAcute cardiac eventsEmergency department environmentCardiac eventsCardiovascular mortalityEarly recurrenceMilitary veteran sampleHypertension riskClinical pathwayPatient experiencePTSD treatmentPTSD onsetTrauma exposureVeteran sampleAutomobile accidentsDepartment environmentMortalityDiseaseRiskTraumaDisorders
2014
Triggering of Symptomatic Atrial Fibrillation by Negative Emotion
Lampert R, Jamner L, Burg M, Dziura J, Brandt C, Liu H, Li F, Donovan T, Soufer R. Triggering of Symptomatic Atrial Fibrillation by Negative Emotion. Journal Of The American College Of Cardiology 2014, 64: 1533-1534. PMID: 25277622, DOI: 10.1016/j.jacc.2014.07.959.Peer-Reviewed Original Research
2003
Depressive Symptoms and Mortality Two Years After Coronary Artery Bypass Graft Surgery (CABG) in Men
Burg MM, Benedetto C, Soufer R. Depressive Symptoms and Mortality Two Years After Coronary Artery Bypass Graft Surgery (CABG) in Men. Psychosomatic Medicine 2003, 65: 508-510. PMID: 12883097, DOI: 10.1097/01.psy.0000077509.39465.79.Peer-Reviewed Original ResearchConceptsCoronary artery bypass graft surgeryElevated depressive symptomsDepressive symptomsCardiovascular mortalityTwo-year cardiovascular mortalityArtery bypass graft surgeryHistory of CHFBypass graft surgeryHistory of COPDLong-term mortalityCABG patientsPresurgical symptomsCABG surgeryCardiac mortalityGraft surgeryImportant independent contributorMedical morbidityPathophysiological mechanismsMortality riskIndependent contributorsSymptomsMortalitySurgeryBDI-1Multivariate model
1997
Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes
Blume P, Dey H, Daley L, Arrighi J, Soufer R, Gorecki G. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. The Journal Of Foot & Ankle Surgery 1997, 36: 120-126. PMID: 9127215, DOI: 10.1016/s1067-2516(97)80057-9.Peer-Reviewed Original ResearchConceptsWhite blood cell scintigraphyPedal osteomyelitisPlain film radiographyBone scanThree-phase bone scanWhite blood cell imagingAbsence of osteomyelitisFilm radiographyWhite blood cellsBony abnormalitiesOsteomyelitisBlood cellsScintigraphyAccurate testDiagnosisBone tissueRadiographyScansPreliminary studyHMPAOMicrobiologicInfectionLeukocytesAbnormalitiesWomen
1996
Comparison of Nifedipine GITS and Hydrochlorothiazide in the Management of Elderly Patients with Stage I–III Diastolic Hypertension*
Dey H, Soufer R, Hoffer P, Wackers F, Black H. Comparison of Nifedipine GITS and Hydrochlorothiazide in the Management of Elderly Patients with Stage I–III Diastolic Hypertension*. American Journal Of Hypertension 1996, 9: 598-606. PMID: 8783785, DOI: 10.1016/0895-7061(96)00168-9.Peer-Reviewed Original ResearchConceptsNifedipine gastrointestinal therapeutic systemGastrointestinal therapeutic systemDiastolic blood pressureBlood pressureDiastolic hypertensionStage IVentricular massCardiovascular functionTreatment differencesGoal diastolic blood pressureSignificant blood pressure reductionWeek placebo washout phasePlacebo washout phaseWeek maintenance phaseBlood pressure reductionGoal blood pressureDiastolic filling rateRenal blood flowGlomerular filtration rateLeft ventricular massBlood urea nitrogenShort-term therapyAdverse side effectsSignificant adverse effectsDiuretic therapy
1995
Prognostic Implications of Mental Stress-Induced Silent Loft Ventricular Dysfunction in Patients With Stable Angina Pectoris
Jain D, Burg M, Soufer R, Zaret B. Prognostic Implications of Mental Stress-Induced Silent Loft Ventricular Dysfunction in Patients With Stable Angina Pectoris. The American Journal Of Cardiology 1995, 76: 31-35. PMID: 7793399, DOI: 10.1016/s0002-9149(99)80796-6.Peer-Reviewed Original ResearchConceptsStable angina pectorisTransient LV dysfunctionAdverse cardiac eventsCardiac eventsLV dysfunctionAngina pectorisMental stressAbnormal cardiovascular reactivityHigher cardiac eventsCohort of patientsCoronary artery diseaseGroup of patientsVentricular function monitoringMental arithmeticVentricular dysfunctionAdverse eventsBaseline characteristicsBeta blockersContinuous ambulatoryArtery diseaseRisk stratificationPrognostic implicationsStress perfusionFunction monitoringHeart rate
1991
Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest
Kayden D, Sigal S, Soufer R, Mattera J, Zaret B, Wackers F. Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. Journal Of The American College Of Cardiology 1991, 18: 1480-1486. PMID: 1939949, DOI: 10.1016/0735-1097(91)90678-3.Peer-Reviewed Original ResearchConceptsInjection of thalliumRedistribution imagesDefect reversibilityThallium-201 reinjectionThallium-201 defectsLate redistribution imagingPoor quality studiesDiagnostic informationClinical variablesRedistribution imagingThallium defectsThallium imagesMyocardial viabilityReversible defectsStress imagingThallium-201PatientsBetter diagnostic informationStress testingExercisePresent studyQuality studiesInjectionLate redistributionReinjection
1990
Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
Setaro J, Zaret B, Schulman D, Black H, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. The American Journal Of Cardiology 1990, 66: 981-986. PMID: 2220622, DOI: 10.1016/0002-9149(90)90937-v.Peer-Reviewed Original ResearchConceptsCongestive heart failureNormal left ventricular systolic performanceLeft ventricular diastolic fillingLeft ventricular systolic performanceVentricular diastolic fillingVentricular systolic performanceDiastolic fillingBlood pressureHeart failureSystolic performanceAbnormal left ventricular diastolic fillingThallium-201 stress scintigraphyAbnormal diastolic fillingEDV/sHeart failure scoreSignificant valvular diseaseMean ejection fractionDiastolic blood pressureSystolic blood pressureLeft ventricular functionPeak filling rateOral verapamilExercise capacityPlacebo valuesSystolic function